Keep your family healthy | Top medical experts educate and help
Home » Hematology » Gene therapy in leukemia. Advanced treatments in hematology. 7
Gene therapy in leukemia. Advanced treatments in hematology. 7
Hematology advanced treatments are developing rapidly. Top expert in hematology oncology talks about gene therapy and precision medicine in video interview. When will gene therapy fulfill its promise in treatment of blood diseases? Hematology advanced treatments. Dr. Anton Titov, MD. Gene therapy holds a lot of promise to advance blood disorders treatments. Video interview with top expert in hematology oncology from Harvard Medical School. Dr. Aric Parnes, MD. Genomics transformation leads to many advanced treatments in hematology disorders. Medical second opinion helps to make sure diagnosis of anemia or leukemia is correct and complete. Hematology advanced treatments for myelodysplastic syndrome and myeloproliferative disease are advancing. Gene therapy is at the forefront of hematology advances. Medical second opinion also helps to choose the best treatment for leukemia and other blood diseases. New genetic diagnostic test “Rapid Heme Panel” allows to quickly and cheaply screen for 95 genetic mutations common in blood disorders. Gene therapy results have not been very good until today. Gene therapy makes big advances and holds a lot of promise for future treatment methods in hematology oncology. Video interview with top expert in blood diseases, hematology and oncology. Medical second opinion confirms that thalassemia diagnosis is correct and complete. Dr. Aric Parnes, MD. Medical second opinion also confirms that thalassemia treatment is required. Medical second opinion helps to choose the best treatment for thalassemia. Dr. Anton Titov, MD. Get medical second opinion on thalassemia and be confident that your treatment is the best. Hematology advanced treatments are available to more patients around the world. Gene therapy of blood disorders will fulfill its promise in the coming decade. Hematology advanced treatment. Gene therapy. Dr. Anton Titov, MD. Hematology oncology is a very complex field. Hematology is at the crossing of many medical and surgical specialties. Where do you see the field of hematology going in the next 10 years? What advances in diagnostics and treatments in hematology will be available to patients in the future? Dr. Aric Parnes, MD Hematologist, Harvard Medical School. Medicine in general has been a very exciting a field to be in and hematology in particular. Hematology is one of the founding specialties of genomics transformation. It is exciting to see how hematology is changing. hematology is changing so quickly. For example, we had very limited understanding of myelodysplastic syndrome before. Now we have understanding of pathophysiology of myelodysplastic syndrome at a molecular level. We also understand how myelodysplastic syndrome affects patients. We understand what we can change (about myelodysplastic syndrome progress and how to treat patients). (rapid advancement of understanding of disease at a molecular level) is going to happen in all fields of medicine. But it is happening right now in hematology. Dr. Anton Titov, MD. Where do you see the most exciting directions in the hematology? Mon-malignant hematology in particular? Dr. Aric Parnes, MD. Certainly genomics is the big factor in hematology, because genetic changes are a root cause of many hematologic diseases. I am hopeful that gene therapy will be a big player in hematology soon. Gene therapy has not been very successful yet. There were problems with gene therapy technology in the past. Some of problems with gene therapy were about finding the right vector to get therapeutic gene into the body in the right method. There were problems in gene therapy to make sure that genetic vector inserts in the right space in a patient’s genome. Dr. Aric Parnes, MD. Correct insertion of genetic vector is necessary so that it does not cause leukemia as a side effect. Gene therapy has been a challenge to hematology advancement. There are ongoing clinical trials in gene therapy in hematology. We are actually hoping to be part of one clinical trial in gene therapy soon. But gene therapy has a long way to go. Gene therapy will eventually realize its promise of breakthrough treatments for hematology patients. Dr. Anton Titov, MD. Dr. Parnes, thank you very much for this very interesting conversation about exciting topics in hematology. We discussed many topics about frequent hematology diseases. Dr. Anton Titov, MD. Thank you very much for sharing your views and your expertise in hematology with us! I hope that our viewers will also find our conversation about hot topics in hematology very useful. Dr. Aric Parnes, MD. Thank you for allowing me to participate! Hematology advanced treatments. Video interview with top expert in hematology. Hematology future. Gene therapy. Progress in genetic diagnostics and therapy.
How can patients avoid mistakes when dealing with a medical problem? Leading doctors share wisdom: